• About us
• Contact

Advertisement

Organisation › Details

EIC Fund (European Innovation Council Fund)

Established in June 2020, the European Innovation Council Fund (EIC Fund) is a breakthrough initiative of the European Commission to make direct equity and quasi-equity investments (between €500.000 and €15 million) in European high impact and deep tech start-ups and scale ups. The EIC Fund provides patient capital and invests in companies from any sector, across all EU countries and countries associated to Horizon 2020. The EIC Fund aims to fill a critical financing gap and its main purpose is not to maximise financial investment returns, but to have a high impact by accompanying companies with disruptive technologies in their growth. Its objective is to crowd in market players, further sharing risks by building a large network of capital providers and strategic partners suitable for co-investments and follow on funding. The Fund pays particular attention to empower and support female founders as well as contributing to reduce the innovation divide among EU countries. *

 

	Start	2020-06-01 established
	Group	EU (govt)
	Industry	fund
	Industry 2	business development (state/region)
	Person	Georgieva, Svetoslava (EU (govt) 202309 Board Chair of EIC Fund)
	City	1049 Brussels
		Address record changed: 2021-07-09
Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	3,600,000,000 (fund size (2021) 2021-01-06)
		* Document for »About Section«: Xenothera. (6/29/21). "Press Release: French Biotech Xenothera Accelerates Its Development with Fundraising of 20 Million Euros". Nantes.
		Record changed: 2023-12-18

Advertisement

More documents for EU (govt)

• [1] CRISPR Therapeutics AG. (2/13/24). "Press Release: European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, Casgevy (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)". Z...
• [2] Roche. (10/30/23). "Press Release: Roche Announces EMBARK Trial in Duchenne Muscular Dystrophy (DMD) Did Not Reach Primary Endpoint, but Shows Positive Efficacy Outcomes on All Timed Functional Key Endpoints". Basel....
• [3] Valneva S.E.. (10/25/23). "Press Release: Valneva Submits Chikungunya Vaccine Marketing Application to EMA and Announces CHMP Accelerated Assessment". Saint Herblain....
• [4] 4SC AG. (10/18/23). "Press Release: 4SC Receives Orphan Drug Designation (ODD) for Resminostat (Kinselby) in CTCL in the European Union". Planegg-Martinsried....
• [5] Kern Tec. (9/27/23). "Press Release: Kern Tec Raises €12 Million in Series A Funding to Scale Technology that Turns Food Waste into Food Ingredients". Vienna....
• [6] BellaSeno GmbH. (7/6/23). "Press Release: BellaSeno Granted Market Access in Europe for Custom-made Bone and Pectus Excavatum Scaffolds"....
• [7] Qiagen N.V.. (2/14/23). "Press Release: Qiagen’s Tuberculosis Blood Test QuantiFERON-TB Gold Plus Gains CE-marking Under New EU IVDR Framework". Venlo....
• [8] Evotec SE. (2/10/23). "Press Release: Evotec Receives € 150 m Loan from European Investment Bank". Hamburg & Toulouse....
• [9] Icosagen AS. (2/8/23). "Press Release: InvestEU – EIB Agrees to a €18 Million Loan to Estonian Biotech Icosagen for Innovative R&D Technologies and New cGMP Production Facility". Tartu....
• [10] European Invesmtent Bank (EIB). (12/20/22). "Press Release: Germany – EIB Provides €20 Million in Financing to Innovative Diagnostics Developer Numares"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.